Detalles de la búsqueda
1.
Treatment of Cancer-Associated Thrombosis: Recent Advances, Unmet Needs, and Future Direction.
Oncologist
; 28(7): 555-564, 2023 07 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37171998
2.
MAA868, a novel FXI antibody with a unique binding mode, shows durable effects on markers of anticoagulation in humans.
Blood
; 133(13): 1507-1516, 2019 03 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-30692123
3.
The effect of sacubitril/valsartan compared to olmesartan on cardiovascular remodelling in subjects with essential hypertension: the results of a randomized, double-blind, active-controlled study.
Eur Heart J
; 38(44): 3308-3317, 2017 Nov 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-29029087
4.
Sacubitril/Valsartan (LCZ696) in Heart Failure.
Handb Exp Pharmacol
; 243: 133-165, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28004291
5.
Dabigatran versus warfarin in patients with mechanical heart valves.
N Engl J Med
; 369(13): 1206-14, 2013 Sep 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-23991661
6.
Effect of small angiokinase inhibitor nintedanib (BIBF 1120) on QT interval in patients with previously untreated, advanced renal cell cancer in an open-label, phase II study.
Invest New Drugs
; 31(5): 1283-93, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23625328
7.
Acceptability of multiple coated mini-tablets in comparison to syrup in infants and toddlers: a randomised controlled study.
Arch Dis Child
; 108(9): 730-735, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36963813
8.
Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial.
Eur Heart J
; 32(22): 2781-9, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21551462
9.
Antithrombotic outcome trials in acute coronary syndromes: seeking the optimal balance between safety and efficacy.
Eur Heart J
; 34(22): 1621-9, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23382466
10.
Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
Clin Ther
; 27(7): 1013-21, 2005 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-16154480
11.
Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Clin Ther
; 27(5): 578-87, 2005 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-15978306
12.
24-hour ambulatory blood-pressure effects of valsartan and hydrochlorothiazide combinations compared with amlodipine in hypertensive patients at increased cardiovascular risk: a VAST sub-study.
Blood Press Monit
; 10(2): 85-91, 2005 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-15812256
13.
Ambulatory blood pressure-lowering effects of valsartan and enalapril after a missed dose in previously untreated patients with hypertension: a prospective, randomized, open-label, blinded end-point trial.
Clin Ther
; 30(1): 108-20, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18343247
Resultados
1 -
13
de 13
1
Próxima >
>>